Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders

• Váldodahkkit: M Dooms (Dahkki), R Saesen (Dahkki), I Steemans (Dahkki), J Lansens (Dahkki), I Huys (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Rare cancers occur with an incidence of no more than six cases per 100,000 people according to the definition used by the Surveillance of Rare Cancers in Europe project. For a variety of reasons (low prevalence, cytotoxicity), it is challenging to perform the necessary clinical studies t...